SHG:688266 - Suzhou Zelgen Biopharmaceuticals Co Ltd

Suzhou Zelgen Biopharmaceutica
Sector: Health Care, Industry: Biotechnology

Add to Watchlist

•  Default
• New Watchlist

   

Yahoo Finance

• Summary
• Financials
• Dividend
• Prices
• Posts
• User
• Alerts

Balance Sheet Cash Flow Income Statement Key Ratios Personalized

Show %	2018 Q3	2018 Q4	2019 Q1	2019 Q2	2019 Q3	2019 Q4	2020 Q1	2020 Q2	2020 Q3	2020 Q4	2021 Q1	2021 Q2	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	Graph
Total Revenue	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	42.41M -	56.17M 32.4%	91.78M 63.4%	43.73M -52.4%	61.67M 41.1%	92.49M 50.0%	104.41M 12.9%	108.11M 3.5%	111.82M 3.4%	62.18M -44.4%	104.33M 67.8%	108.24M 3.7%
Cost of Revenue	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	2.05M -	1.71M -16.6%	2.51M 46.6%	3.38M 34.9%	5.05M 49.3%	8.31M 64.3%	9.42M 13.4%	7.49M -20.5%	9M 20.3%	4.96M -44.9%	7.76M 56.5%	7.15M -7.9%
Gross Profit	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	40.36M -	54.46M 34.9%	89.27M 63.9%	40.34M -54.8%	56.62M 40.4%	84.19M 48.7%	95M 12.8%	100.62M 5.9%	102.81M 2.2%	57.22M -44.3%	96.57M 68.8%	101.1M 4.7%
Total Expenses	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	157.56M 54.6%	190.71M 21.0%	242.79M 27.3%	179.87M -25.9%	201.98M 12.3%	219.47M 8.7%	204.81M -6.7%	170.36M -16.8%	176.99M 3.9%	168.93M -4.6%	195.88M 16.0%	163.24M -16.7%
Operating Expense	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	155.51M 52.6%	189M 21.5%	240.28M 27.1%	176.48M -26.6%	196.93M 11.6%	211.16M 7.2%	195.4M -7.5%	162.88M -16.6%	167.98M 3.1%	163.97M -2.4%	188.12M 14.7%	156.1M -17.0%
Operating Income	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-115.15M -	-134.54M -	-151M -	-136.14M -	-140.31M -	-126.97M -	-100.4M -	-62.25M -	-65.17M -	-106.75M -	-91.55M -	-55M -
Net Income (Cont Operations)	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-185.64M -	-	-	-	-262.97M -	-	-	-	-120.8M -	-	-	-
Net Income	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-97.26M -	-115.7M -	-158.33M -	-119.44M -	-127.57M -	-116.74M -	-93.58M -	-57.23M -	-57M -	-87.86M -	-76.49M -	-39.5M -
Basic EPS	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-0.41 -	-0.48 -	-0.66 -	-0.5 -	-0.53 -	-0.49 -	-0.39 -	-0.24 -	-0.22 -	-0.34 -	-0.29 -	-0.15 -
Diluted EPS	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-0.41 -	-0.48 -	-0.66 -	-0.5 -	-0.53 -	-0.49 -	-0.39 -	-0.24 -	-0.22 -	-0.34 -	-0.29 -	-0.15 -